Older AdultsAnxiety DisordersSubstance Use Disorders (SUD)Equity and EthicsLSDPsilocybin

Psychedelic use and intimate partner violence

In a community sample of 1,266, men reporting lifetime LSD and/or psilocybin use were less likely to perpetrate physical intimate partner violence (OR=0.42). Improved emotion regulation statistically mediated this association, and no comparable effect was observed among women.

Authors

  • Zachary Walsh
  • Adele Lafrance

Published

Journal of Psychopharmacology
individual Study

Abstract

Background

Recent evidence suggests that psychedelic use predicts reduced perpetration of intimate partner violence among men involved in the criminal justice system. However, the extent to which this association generalizes to community samples has not been examined, and potential mechanisms underlying this association have not been directly explored.

Aims

The present study examined the association between lifetime psychedelic use and intimate partner violence among a community sample of men and women. The study also tested the extent to which the associations were mediated by improved emotion regulation.

Methods

We surveyed 1266 community members aged 16–70 (mean age=22.78, standard deviation =7.71) using an online questionnaire that queried substance use, emotional regulation, and intimate partner violence. Respondents were coded as psychedelic users if they reported one or more instance of using lysergic acid diethylamide and/or psilocybin mushrooms in their lifetime. Results/outcomes: Males reporting any experience using lysergic acid diethylamide and/or psilocybin mushrooms had decreased odds of perpetrating physical violence against their current partner (odds ratio=0.42, p<0.05). Furthermore, our analyses revealed that male psychedelic users reported better emotion regulation when compared to males with no history of psychedelic use. Better emotion regulation mediated the relationship between psychedelic use and lower perpetration of intimate partner violence. This relationship did not extend to females within our sample. Conclusions/interpretation: These findings extend prior research showing a negative relationship between psychedelic use and intimate partner violence, and highlight the potential role of emotion regulation in this association.

Available with Blossom Pro

Research Summary of 'Psychedelic use and intimate partner violence'

Introduction

The relationship between substance use and violent behaviour has been widely studied, with strong evidence linking alcohol, methamphetamine, cocaine and PCP to increased aggression. In contrast, the literature on hallucinogens and aggression is mixed: earlier studies report both risk and protective associations, while more recent reviews and longitudinal work suggest that classic psychedelics (compounds acting primarily as 5-HT2A agonists such as LSD and psilocybin) may be associated with reduced antisocial behaviour. Psychedelic experiences are heterogeneous and can produce acute anxiety or rare adverse reactions, but contemporary clinical and observational studies have also reported salutary effects on internalising disorders and on some externalising outcomes such as problematic substance use and criminality. St and colleagues designed the present study to test whether lifetime use of LSD and/or psilocybin mushrooms is associated with perpetration of intimate partner violence (IPV) in a community sample, and whether emotion regulation might mediate any observed association. The investigators hypothesised that prior psychedelic use would be linked to lower odds of IPV perpetration, that psychedelic users would report better emotion regulation, and that emotion regulation would at least partly explain the relationship between psychedelic use and reduced IPV. The study therefore aimed to extend prior findings from correctional samples to a broader community population and to explore a plausible psychological mechanism for any protective effect.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (14)

Papers cited by this study that are also in Blossom

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

Hendricks, P. S., Clark, B., Johnson, M. W. et al. · Journal of Psychopharmacology (2014)

89 cited
The relationships of classic psychedelic use with criminal behavior in the United States adult population

Hendricks, P. S., Crawford, M. S., Cropsey, K. L. et al. · Journal of Psychopharmacology (2017)

Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers

Kraehenmann, R., Preller, K. H., Scheidegger, M. et al. · Biological Psychiatry (2015)

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Krebs, T. S., Johansen, P. Ø. · Journal of Psychopharmacology (2012)

Show all 14 references
Psychedelic medicine: a re-emerging therapeutic paradigm

Tupper, K. W., Wood, E., Yensen, R. et al. · Canadian Medical Association Journal (2015)

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A. et al. · NeuroReport (1998)

Cited By (10)

Papers in Blossom that reference this study

Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis

Agin-Liebes, G. I., Nielson, E. M., Zingman, M. et al. · Psychology of Addictive Behaviors (2024)

Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting

Argento, E., Socias, M. E., Hayashi, K. et al. · International Journal of Drug Policy (2022)

Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes

Agin-Liebes, G. I., Lancelotta, R., Uthaug, M. V. et al. · ACS Pharmacology and Translational Science (2021)

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.

Araújo, D. B., Zeifman, R. J., Palhano-Fontes, F. et al. · Frontiers in Pharmacology (2019)

96 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.